Ipsen Drug Misses Goal in Late-Stage Trial for Rare Liver Disease

Bylvay missed the study’s primary objective of showing an improvement in native liver survival rates compared…

Novo Nordisk Seeks Injunction Against Eli Lilly in Dispute Over Weight-Loss Ads

Novo Nordisk is asking a U.S. court to preliminarily halt rival Eli Lilly from advertising weight-loss…

Measles cases in the U.S. during the first seven months of this year have surpassed all of 2025’s tally, setting a new three-decade high

Back-to-back years of thousands of cases set the stage for the country to lose its measles…

Public-health officials are investigating four additional states as part of a multistate cyclospora outbreak linked to iceberg lettuce that they warn could be even broader

The outbreak stems from consumption of iceberg lettuce from Taylor Farms, health officials say.

He wears leather jackets to the office, hates “me-too” drugs, and holds over 1,000 patents worldwide. With stock pressure mounting, can Regeneron’s resident maverick find his next blockbuster?

At Regeneron, George Yancopoulos is the rare scientist and executive who drives growth with discoveries instead…

The Food and Drug Administration’s Pharmacy Compounding Advisory Committee voted in favor of several unapproved peptides up for compounding consideration.

Against warnings from career scientists, an FDA committee voted in favor of easing restrictions on six…

The Houthis Have Opened a New Front in the U.S.-Iran War

The Yemeni militants have set up a standoff in one of the world’s most vital waterways…

Inside Ukraine’s Secretive Unit Knocking Russian Drones Out of the Sky

Russia is launching its largest aerial attacks of the war—and WSJ embeds with an elite drone…

Europe’s Heat Waves Fuel Rash of Wildfires

Authorities have evacuated tens of thousands of people, including from affluent tourist sites engulfed in the…

Tensions Rise After Deadly Clash Near Palestinian Village in West Bank

Two Israelis and four Palestinians were killed by gunfire in the latest flare-up.